LarissaA.KordeMDMPH

Oncology • Washington, DC

Breast Cancer, Hematologic Oncology

Associate professor

Join to view full profile

Dr. Korde is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Korde's full profile

Already have an account?

Office
5255 Loughboro Rd NW
Washington, DC 20016
Phone+1 301-402-2183

Fax+1 301-496-1854

Education & Training

National Institutes of Health Clinical CenterFellowship, Medical Oncology, 2002 - 2004
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1998 - 2001
New York Medical CollegeClass of 1998

Certifications & Licensure

MD State Medical License 2019 - 2026
DC State Medical License 2001 - 2024
WA State Medical License 2009 - 2020
VA State Medical License 1998 - 2001
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries Start of enrollment: 2005 Nov 28
Completed
Phase 2
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Start of enrollment: 2010 Mar 01
Recruiting
Phase 2
Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors Start of enrollment: 2010 Sep 01
Active, not recruiting
Phase 2
Prevention Strategy for Pre-Menopausal Women at High Risk for Development of Breast Cancer Start of enrollment: 2011 Jan 01
Terminated
Phase 2
NCI COVID-19 in Cancer Patients, NCCAPS Study Start of enrollment: 2020 Jun 05
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

233 citations
Current Landscape of Immunotherapy in Breast Cancer: A Review
Sylvia Adams, Margaret E. Gatti-Mays, Kevin Kalinsky, Larissa A. Korde, Elad Sharon
JAMA Oncology. 2019-08-01
678 citations
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
Andrew Tutt, Judy Garber, Bella Kaufman, Giuseppe Viale, Debora Fumagalli
The New England Journal of Medicine. 2021-06-03
266 citations
Genetics of breast cancer: a topic in evolution
Stacey Shiovitz, L. A. Korde
Annals of Oncology. 2015-07-01

Journal Articles

Prognostic Gene Expression Profiling in Cutaneous Melanoma
Douglas Grossman, Sancy A Leachman, Larissa Korde, Elizabeth I Buchbinder, Emily Y Chu, Julia A Curtis, Laura K Ferris, Kenneth F Grossmann, Siwen Hu-Lieskovan, Joanne..., JAMA Dermatology

Abstracts/Posters

Low-Dose Tamoxifen (LDTam) As a Breast Cancer (BC) Risk-Reduction Strategy in Lymphoma Survivors Exposed to Chest Radiation Therapy (RT) during Adolescence/Young Adult...
Larissa Korde, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Authored Content

Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020

Press Mentions

Neoadjuvant Immunotherapy Improves Outlook in High-Risk MelanomaFebruary 24th, 2023
A Safer, Better Treatment Option for Some Younger Women With Breast CancerJanuary 11th, 2023
Neoadjuvant Immunotherapy Improves Outlook in High-Risk MelanomaSeptember 11th, 2022
Join now to see all